Editorial: Advances in molecular biology knowledge of rectal cancer and forthcoming role of liquid biopsy.
作者信息
Negri Francesca, Gnetti Letizia, Aschele Carlo
机构信息
Gastroenterology and Endoscopy Unit, University Hospital of Parma, Parma, Italy.
Department of Pathology, University Hospital of Parma, Parma, Italy.
出版信息
Front Oncol. 2024 Aug 29;14:1476174. doi: 10.3389/fonc.2024.1476174. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Advances in molecular biology knowledge of rectal cancer and forthcoming role of liquid biopsy.社论：直肠癌分子生物学知识的进展及液体活检即将发挥的作用
Front Oncol. 2024 Aug 29;14:1476174. doi: 10.3389/fonc.2024.1476174. eCollection 2024.
2
ctDNA on liquid biopsy for predicting response and prognosis in locally advanced rectal cancer: A systematic review.用于预测局部晚期直肠癌反应和预后的液体活检中的循环肿瘤DNA：一项系统综述。
Eur J Surg Oncol. 2022 Jan;48(1):218-227. doi: 10.1016/j.ejso.2021.08.034. Epub 2021 Sep 3.
3
Liquid biopsy for rectal cancer: A systematic review.液体活检在直肠癌中的应用：系统评价。
Cancer Treat Rev. 2019 Sep;79:101893. doi: 10.1016/j.ctrv.2019.101893. Epub 2019 Aug 31.
4
A prospective feasibility study evaluating the role of multimodality imaging and liquid biopsy for response assessment in locally advanced rectal carcinoma.一项前瞻性可行性研究，评估多模态成像和液体活检测技术在局部晚期直肠癌反应评估中的作用。
Abdom Radiol (NY). 2019 Nov;44(11):3641-3651. doi: 10.1007/s00261-019-02135-8.
5
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.循环肿瘤DNA：癌症液体活检中有前景的生物标志物。
Oncotarget. 2016 Jul 26;7(30):48832-48841. doi: 10.18632/oncotarget.9453.
6
Update on liquid biopsy in clinical management of non-small cell lung cancer.非小细胞肺癌临床管理中液体活检的最新进展。
Onco Targets Ther. 2019 Jul 1;12:5097-5109. doi: 10.2147/OTT.S203070. eCollection 2019.
7
Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy.循环肿瘤细胞（CTC）生物学探索：液体活检中的范式转变
Indian J Clin Biochem. 2021 Apr;36(2):131-142. doi: 10.1007/s12291-020-00923-4. Epub 2020 Sep 16.
8
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer.当前前列腺癌诊断方法的评估，重点是液体活检和前列腺癌。
Expert Rev Mol Diagn. 2020 Feb;20(2):207-217. doi: 10.1080/14737159.2019.1684265. Epub 2019 Oct 29.
9
Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021.2021 年液体活检中基于下一代测序的非小细胞肺癌检测。
Crit Rev Oncol Hematol. 2021 May;161:103311. doi: 10.1016/j.critrevonc.2021.103311. Epub 2021 Mar 26.
10
Advances in liquid biopsy in neuroblastoma.神经母细胞瘤液体活检的进展
Fundam Res. 2022 Aug 17;2(6):903-917. doi: 10.1016/j.fmre.2022.08.005. eCollection 2022 Nov.
引用本文的文献
1
Rectal Cancer: Exploring Predictive Biomarkers Through Molecular Pathways Involved in Carcinogenesis.直肠癌：通过参与致癌作用的分子途径探索预测性生物标志物
Biology (Basel). 2024 Dec 3;13(12):1007. doi: 10.3390/biology13121007.
本文引用的文献
1
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy.国际验证免疫评分活检在观察等待策略管理的直肠癌患者中的应用。
J Clin Oncol. 2024 Jan 1;42(1):70-80. doi: 10.1200/JCO.23.00586. Epub 2023 Oct 3.
2
Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications.解析结直肠癌的复杂性：异质性、克隆进化及临床意义
Cancers (Basel). 2023 Aug 8;15(16):4020. doi: 10.3390/cancers15164020.
3
Preoperative Treatment of Locally Advanced Rectal Cancer.局部进展期直肠癌的术前治疗。
N Engl J Med. 2023 Jul 27;389(4):322-334. doi: 10.1056/NEJMoa2303269. Epub 2023 Jun 4.
4
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer.直肠癌新辅助治疗反应的基因组和转录组决定因素。
Nat Med. 2022 Aug;28(8):1646-1655. doi: 10.1038/s41591-022-01930-z. Epub 2022 Aug 15.
5
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.PD-1 阻断在错配修复缺陷、局部晚期直肠癌中的应用。
N Engl J Med. 2022 Jun 23;386(25):2363-2376. doi: 10.1056/NEJMoa2201445. Epub 2022 Jun 5.
6
Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models.预测直肠癌新辅助放化疗的反应：从生物标志物到肿瘤模型
Ther Adv Med Oncol. 2022 Feb 21;14:17588359221077972. doi: 10.1177/17588359221077972. eCollection 2022.
7
Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.在接受结直肠癌肝转移根治性切除术后患者中循环肿瘤 DNA 动力学与复发风险：一项前瞻性队列研究。
PLoS Med. 2021 May 3;18(5):e1003620. doi: 10.1371/journal.pmed.1003620. eCollection 2021 May.
8
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.局部晚期直肠癌患者的 FOLFIRINOX 新辅助化疗和术前放化疗（UNICANCER-PRODIGE 23）：一项多中心、随机、开放标签、III 期临床试验。
Lancet Oncol. 2021 May;22(5):702-715. doi: 10.1016/S1470-2045(21)00079-6. Epub 2021 Apr 13.
9
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.短程放疗联合化疗后行全直肠系膜切除术（TME）与术前放化疗、TME 及辅助化疗在局部进展期直肠癌（RAPIDO）中的应用：一项随机、开放标签、3 期临床试验。
Lancet Oncol. 2021 Jan;22(1):29-42. doi: 10.1016/S1470-2045(20)30555-6. Epub 2020 Dec 7.
10
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.ctDNA 在结直肠癌中的应用及整合：NCI 结肠和直肠分析工作组白皮书。
Nat Rev Clin Oncol. 2020 Dec;17(12):757-770. doi: 10.1038/s41571-020-0392-0. Epub 2020 Jul 6.
Zotero 插件